Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.35 |
| ▸ | CTSD | P07339 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5998392 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL6156562 | 0.89 | ALDH1A1 (0.43) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL5669568 | 0.89 | ALDH1A1 (0.43) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL8035923 | 0.89 | ALDH1A1 (0.43) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL29437612 | 0.86 | ALDH1A1 (0.41) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL5257837 | 0.86 | ALDH1A1 (0.41) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL5257839 | 0.86 | ALDH1A1 (0.41) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL1263085 | 0.86 | ALDH1A1 (0.41) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL9264654 | 0.85 | ALDH1A1 (0.40) | ALDH1A1LMNAHPGDKDM4ERCE1 | |
| SCHEMBL9021352 | 0.85 | ALDH1A1 (0.40) | ALDH1A1LMNAHPGDKDM4ERCE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060287527-A1 | Process for producing acrylic acid derivative | NIPPON SODA CO., LTD. (JP) | 2006-12-21 | — | — | US | disclosed |
| US-20040152894-A1 | Process for producing acrylic acid derivative | NIPPON SODA CO. LTD (JP) | 2004-08-05 | — | — | US | disclosed |
| EP-1142857-A1 | PROCESSES FOR PRODUCING ACRYLIC ACID DERIVATIVE | NIPPON SODA CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152894-A1 | Process for producing acrylic acid derivative | OXGR1, GART, HAO2 | ALDH1A1 117/4885LMNA 4006/4885HPGD 1251/4885 |
| US-20060287527-A1 | Process for producing acrylic acid derivative | APEH, HAAO, ASNS | ALDH1A1 214/4885LMNA 4324/4885HPGD 1416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.